Keyphrases
Indonesia
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
76%
Antiretroviral Therapy
43%
Bali Indonesia
36%
COVID-19
36%
Surabaya
31%
HHV-8
27%
CRF01_AE
26%
Infected Individual
25%
AIDS/HIV
24%
Transmitted Drug Resistance
21%
Buleleng
20%
East Java Indonesia
19%
Human Detection
18%
HIV Patients
18%
Nave
17%
Drug Resistance mutations
17%
HIV Drug Resistance
15%
Antiretroviral Naïve
15%
Immunoglobulin G Antibodies
12%
Bali
11%
Regency
11%
Immunoglobulin G
10%
Treatment-naïve
10%
Genotypic Analysis
10%
People Living with Human Immunodeficiency Virus
9%
HIV Viral Load
9%
Pontianak
9%
Human Herpesvirus 6 (HHV-6)
9%
Viral Shedding
9%
Boron-modified
9%
COVID-19 Antibody
9%
Type Distribution
9%
Room Temperature
9%
Rotavirus Infection
9%
Transmitted Drug Resistance mutations
9%
Treatment Experience
9%
Diarrhea
9%
Jakarta
9%
Moderate to Severe
9%
TH01
9%
Drug Resistance Patterns
9%
Cytokine Profile
9%
SARS-CoV-2 Infection
9%
Transmission Dynamics
9%
Potential Utilization
9%
Antibody Detection
9%
Makassar
9%
Children under Five Years
9%
Genotypic Characterization
9%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
63%
Drug Resistance
46%
Human Immunodeficiency Virus 1
32%
Human Herpesvirus 8
27%
Infection
23%
SARS Coronavirus
19%
Diarrhea
18%
Prevalence
17%
Diseases
16%
Rotavirus
14%
Coronavirinae
13%
Immunoglobulin G
12%
Acquired Immune Deficiency Syndrome
10%
Immunoglobulin G Antibody
10%
HIV Drug Resistance
10%
Rotavirus Infection
10%
Quantum Dot
9%
Molecular Epidemiology
9%
Carbon Quantum Dot
9%
RNA Directed DNA Polymerase
7%
Amino Acid
5%
Proteinase
5%
Immunology and Microbiology
Human Immunodeficiency Virus
61%
Human Immunodeficiency Virus 1
54%
Drug Resistance
35%
Human Herpesvirus 8
27%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Immunoglobulin G
11%
Reverse Transcriptase
11%
COVID-19
9%
Immunoglobulin G Antibody
9%
Coronavirinae
9%
Human Herpesvirus 6
9%
Dynamics
9%
Cytokine
9%
Viral Shedding
9%
HIV Type 1
9%
Viral Load
9%
Molecular Epidemiology
9%
Heat Shock
9%
Rotavirus
9%
Virus
7%
Blood Plasma
7%
Structural Gene
6%
Prevalence
6%
Cladistics
6%
Env (Gene)
5%